Representatives McCormick & DeLauro Introduce CLEAR LABELS Act with Senator Rick Scott in the Senate
WASHINGTON, D.C — Today, Representatives Rich McCormick (GA-07) and Rosa DeLauro (CT-03) have introduced the bipartisan Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act, with Senators Rick Scott (R-FL) and Kirsten Gillibrand (D-NY) leading the effort in the Senate.
Many prescription drugs, and the active pharmaceutical ingredients (APIs) they rely on, are manufactured overseas, including in Communist China. Current federal labeling rules do not require disclosure of where these ingredients or finished drugs are made, leaving patients and providers without key information. The CLEAR LABELS Act would change that. It requires prescription drug labels to clearly list the original manufacturers of both the drugs and their APIs, giving Americans the transparency they deserve and ensuring stronger accountability in the pharmaceutical supply chain.
"I'm proud to be the House co-lead of the CLEAR LABELS Act. This bipartisan and bicameral bill will bring transparency to consumers, pharmacists, and providers about the country of origin of pharmaceuticals and APIs while empowering stakeholders with knowledge of where their medications come from,”said Representative Rich McCormick (GA-07). “Americans deserve to know where their prescription drugs, or the APIs used to make them, are manufactured. I'm proud to work alongside Representative DeLauro and Senators Scott and Gillibrand to pass this legislation.”
"American patients deserve to know where their medications and their ingredients come from,” said Representative Rosa DeLauro (CT-03). “Right now, federal law leaves patients, pharmacists, and providers completely in the dark about whether the drugs they rely on were manufactured in a facility with strong safety standards or in a country with weak oversight. The CLEAR LABELS Act changes that. By requiring transparency on the country of origin for finished drug products, active pharmaceutical ingredients, and the key starting materials used to make them, we will begin to address our dangerous overreliance on overseas pharmaceutical supply chains. I'm proud to co-lead this legislation and look forward to working with my colleagues in the House and Senate to make it law."
Senator Rick Scott (R-FL)said, “As parents and grandparents, we do everything we can to make informed, safe decisions that keep our families safe and healthy. But right now, families are kept in the dark about where the drugs they rely on are coming from. America’s drug supply is dependent on our adversaries like Communist China and nations such as India to manufacture our drugs and their ingredients, often with limited transparency and oversight. This broken process leaves patients clueless about where their drugs come from. Families deserve to have confidence that the medicines they take are safe, regulated, and clearly labeled. That’s why I’m leading the bipartisan, and now bicameral, CLEAR LABELS Act to ensure your medicines have clear and upfront country-of-origin labeling to help ensure every American can feel comfortable knowing what’s in their medicine cabinet. I appreciate my colleagues in the Senate for joining me in this effort, and I’m thankful to Congressman McCormick for leading the way in the House.”
“Americans deserve to know where their prescription drugs are manufactured so they can make informed health care decisions,” said Senator Kirsten Gillibrand (D-NY). “The CLEAR LABELS Act would shine a light on pharmaceutical manufacturing by making this information readily accessible to patients, pharmacists, and providers while strengthening accountability across the supply chain. As the top Democrat on the Senate Aging Committee, I will keep fighting to make sure every American has access to safe, effective, lifesaving medications and the clear, reliable information they need.”
###